Study on lifestyle-related disease improvement effect by the kombu intake

Study on lifestyle-related disease improvement effect by the kombu intake - Study on lifestyle-related disease improvement effect by the kombu

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009799

Enrollment

540

Registered

2013-01-17

Start date

2013-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, hyperlipemia, gout, glycohemia, diabetes, abnormal glucose tolerance, a fatty liver, obstipation, healthy

Interventions

kombu intake for 4 weeks (6 g/1 day)&gt

&gt

Non intake for 4 weeks or Non intake for 4 weeks &gt

kombu intake for 4 weeks (6 g/1 day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Person who does not present allergy to the kombu 2) Person aged 20 and over 3) Person by whom written consent was got from the person himself/herself 4) Person who does not have thyroid disease

Exclusion criteria

Exclusion criteria: The case that is judged that doctors are unsuitable

Design outcomes

Primary

Measure	Time frame
Validity of the kombu intake to hypertension, hyperlipemia, gout, glycohemia, diabetes, abnormal glucose tolerance, a fatty liver, and obstipation-Evaluation of blood components, urine components and various pathological condition	—

Countries

Japan

Contacts

Public ContactMasaru Yoshida

Kobe University Graduate School of Medicine Division of Gastroenterology

myoshida@med.kobe-u.ac.jp078-382-6305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026